S&P 500   5,081.91 (+0.24%)
DOW   38,922.99 (-0.07%)
QQQ   437.13 (+0.43%)
AAPL   179.76 (-0.92%)
MSFT   408.32 (+0.15%)
META   486.70 (+0.55%)
GOOGL   136.91 (+0.39%)
AMZN   174.77 (+0.93%)
TSLA   199.96 (-1.03%)
NVDA   789.20 (+1.62%)
NIO   5.65 (+4.05%)
AMD   188.75 (+6.92%)
BABA   74.10 (-0.66%)
T   16.97 (+0.06%)
F   12.38 (+0.65%)
MU   89.49 (-0.25%)
CGC   3.29 (-2.08%)
GE   155.72 (+0.07%)
DIS   111.36 (+0.51%)
AMC   4.28 (-14.23%)
PFE   26.78 (-0.96%)
PYPL   60.19 (-0.10%)
XOM   104.66 (+0.33%)
S&P 500   5,081.91 (+0.24%)
DOW   38,922.99 (-0.07%)
QQQ   437.13 (+0.43%)
AAPL   179.76 (-0.92%)
MSFT   408.32 (+0.15%)
META   486.70 (+0.55%)
GOOGL   136.91 (+0.39%)
AMZN   174.77 (+0.93%)
TSLA   199.96 (-1.03%)
NVDA   789.20 (+1.62%)
NIO   5.65 (+4.05%)
AMD   188.75 (+6.92%)
BABA   74.10 (-0.66%)
T   16.97 (+0.06%)
F   12.38 (+0.65%)
MU   89.49 (-0.25%)
CGC   3.29 (-2.08%)
GE   155.72 (+0.07%)
DIS   111.36 (+0.51%)
AMC   4.28 (-14.23%)
PFE   26.78 (-0.96%)
PYPL   60.19 (-0.10%)
XOM   104.66 (+0.33%)
S&P 500   5,081.91 (+0.24%)
DOW   38,922.99 (-0.07%)
QQQ   437.13 (+0.43%)
AAPL   179.76 (-0.92%)
MSFT   408.32 (+0.15%)
META   486.70 (+0.55%)
GOOGL   136.91 (+0.39%)
AMZN   174.77 (+0.93%)
TSLA   199.96 (-1.03%)
NVDA   789.20 (+1.62%)
NIO   5.65 (+4.05%)
AMD   188.75 (+6.92%)
BABA   74.10 (-0.66%)
T   16.97 (+0.06%)
F   12.38 (+0.65%)
MU   89.49 (-0.25%)
CGC   3.29 (-2.08%)
GE   155.72 (+0.07%)
DIS   111.36 (+0.51%)
AMC   4.28 (-14.23%)
PFE   26.78 (-0.96%)
PYPL   60.19 (-0.10%)
XOM   104.66 (+0.33%)
S&P 500   5,081.91 (+0.24%)
DOW   38,922.99 (-0.07%)
QQQ   437.13 (+0.43%)
AAPL   179.76 (-0.92%)
MSFT   408.32 (+0.15%)
META   486.70 (+0.55%)
GOOGL   136.91 (+0.39%)
AMZN   174.77 (+0.93%)
TSLA   199.96 (-1.03%)
NVDA   789.20 (+1.62%)
NIO   5.65 (+4.05%)
AMD   188.75 (+6.92%)
BABA   74.10 (-0.66%)
T   16.97 (+0.06%)
F   12.38 (+0.65%)
MU   89.49 (-0.25%)
CGC   3.29 (-2.08%)
GE   155.72 (+0.07%)
DIS   111.36 (+0.51%)
AMC   4.28 (-14.23%)
PFE   26.78 (-0.96%)
PYPL   60.19 (-0.10%)
XOM   104.66 (+0.33%)

Nocturne Acquisition (MBTC) Competitors

$10.50
0.00 (0.00%)
(As of 02/28/2024 ET)

MBTC vs. VANI, SHFS, HYPR, ECOR, DKDCA, PXDT, POCI, MOVE, ROCG, and FNVT

Should you be buying Nocturne Acquisition stock or one of its competitors? The main competitors of Nocturne Acquisition include Vivani Medical (VANI), SHF (SHFS), Hyperfine (HYPR), electroCore (ECOR), Data Knights Acquisition (DKDCA), Pixie Dust Technologies (PXDT), Precision Optics (POCI), Movano (MOVE), Roth CH Acquisition IV (ROCG), and Finnovate Acquisition (FNVT).

Nocturne Acquisition vs.

Vivani Medical (NASDAQ:VANI) and Nocturne Acquisition (NASDAQ:MBTC) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Vivani Medical's return on equity of 0.00% beat Nocturne Acquisition's return on equity.

Company Net Margins Return on Equity Return on Assets
Vivani MedicalN/A -76.19% -51.59%
Nocturne Acquisition N/A N/A -7.12%

8.4% of Vivani Medical shares are held by institutional investors. Comparatively, 22.9% of Nocturne Acquisition shares are held by institutional investors. 55.6% of Vivani Medical shares are held by insiders. Comparatively, 0.6% of Nocturne Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Vivani Medical had 8 more articles in the media than Nocturne Acquisition. MarketBeat recorded 11 mentions for Vivani Medical and 3 mentions for Nocturne Acquisition. Vivani Medical's average media sentiment score of 0.93 beat Nocturne Acquisition's score of 0.25 indicating that Nocturne Acquisition is being referred to more favorably in the news media.

Company Overall Sentiment
Vivani Medical Neutral
Nocturne Acquisition Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vivani MedicalN/AN/A-$13.89M-$0.56-7.61
Nocturne AcquisitionN/AN/A-$1.21MN/AN/A

Vivani Medical received 1 more outperform votes than Nocturne Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Vivani MedicalOutperform Votes
1
100.00%
Underperform Votes
No Votes
Nocturne AcquisitionN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivani Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Nocturne Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Vivani Medical has a beta of 2.57, indicating that its stock price is 157% more volatile than the S&P 500. Comparatively, Nocturne Acquisition has a beta of -0.01, indicating that its stock price is 101% less volatile than the S&P 500.

Summary

Nocturne Acquisition beats Vivani Medical on 5 of the 9 factors compared between the two stocks.


Get Nocturne Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for MBTC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MBTC vs. The Competition

MetricNocturne AcquisitionElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$54.50M$3.15B$4.95B$7.48B
Dividend YieldN/A1.69%2.87%3.87%
P/E RatioN/A11.23203.6714.99
Price / SalesN/A72.782,922.9266.71
Price / CashN/A14.3894.4854.64
Price / Book-6.564.244.454.67
Net Income-$1.21M$88.40M$112.73M$211.02M
7 Day Performance-4.46%7.47%4.92%2.90%
1 Month Performance10.18%7.85%10.04%4.00%
1 Year Performance-2.60%51.13%12.55%8.23%

Nocturne Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VANI
Vivani Medical
1.046 of 5 stars
$1.07
flat
N/A+263.1%$54.60MN/A-1.9150News Coverage
Gap Down
SHFS
SHF
2.5656 of 5 stars
$1.06
+1.0%
$1.50
+41.5%
+22.4%$49.39M$9.48M-0.4465Gap Up
HYPR
Hyperfine
2.0796 of 5 stars
$1.01
-9.0%
$2.38
+135.1%
-20.1%$72.32M$9.77M-1.53136News Coverage
High Trading Volume
ECOR
electroCore
2.5956 of 5 stars
$7.03
+1.7%
$10.00
+42.2%
+94.9%$42.18M$8.59M-1.6962Positive News
Gap Up
DKDCA
Data Knights Acquisition
0 of 5 stars
$0.94
-1.1%
N/A-93.7%$40.14MN/A-4.952,021Gap Up
High Trading Volume
PXDT
Pixie Dust Technologies
0 of 5 stars
$2.50
+5.5%
N/AN/A$36.75M$5.18M0.0078Short Interest ↑
High Trading Volume
POCI
Precision Optics
0 of 5 stars
$5.67
-3.2%
N/A-23.8%$35.55M$19.22M-18.9084Positive News
Gap Up
MOVE
Movano
0 of 5 stars
$0.58
-9.4%
N/A-52.2%$31.87MN/A-0.7434Short Interest ↑
High Trading Volume
ROCG
Roth CH Acquisition IV
0 of 5 stars
$1.46
-19.3%
N/A-87.3%$21.66MN/A0.002,021Gap Up
High Trading Volume
FNVT
Finnovate Acquisition
0 of 5 stars
$11.17
flat
N/A+7.4%$101.54MN/A0.002,021Positive News

Related Companies and Tools

This page (NASDAQ:MBTC) was last updated on 2/29/2024 by MarketBeat.com Staff